Puma Biotech Plunges on Sharp Drop in Cancer-Drug Sales - TheStreet
Puma Biotech (PBYI) Inks Agreement for Takeda's Alisertib
Puma Biotechnology
Puma Biotechnology
Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha
Exhibitor Puma Biotechnology 02-20 - Scripps CME Connection
Former Puma Biotech executive gets U.S. prison term for insider trading | Reuters.com
PumaBiotech (@pumabiotech) / Twitter
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology: Risky Investment (NASDAQ:PBYI) | Seeking Alpha
Puma Biotech Strikes Deal to Develop and Market its Breast Cancer Drug in China - Los Angeles Business Journal
Puma Biotechnology
Puma Biotechnology Reports Results of Neratinib (PB272) in P-III NALA Trial for 3L HER2-Positive Metastatic Breast Cancer
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire
Puma Biotechnology
Puma Biotechnology - Crunchbase Company Profile & Funding
Why Puma Biotechnology Shares Dropped 17.7% This Week | The Motley Fool
Puma Biotechnology
Puma Biotechnology Inc
Puma Biotech shares slide after glimpse of trial data on cancer drug | Financial Times
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
SEC charges former Puma biotech exec with $1.1 million in insider trading
Puma Biotech plunges on drug side effects
PumaBiotech (@pumabiotech) / Twitter
